Mackenzie Financial Corp Liva Nova PLC Transaction History

Mackenzie Financial Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	BUY	$57.25 - $86.63 $38,701 - $58,561	676 Added 22.22%	3,718 $232,000
Q1 2022 May 13, 2022	BUY	$71.02 - $86.99 $10,724 - $13,135	151 Added 5.22%	3,042 $249,000
Q4 2021 Feb 14, 2022	SELL	$76.72 - $92.68 $15,344 - $18,536	-200 Reduced 6.47%	2,891 $253,000
Q3 2021 Nov 08, 2021	BUY	$76.02 - $88.62 $234,977 - $273,924	3,091 New	3,091 $245,000
Q1 2019 May 15, 2019	SELL	$86.15 - $100.49 $460,902 - $537,621	-5,350 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$84.14 - $125.42 $450,149 - $670,997	5,350 New	5,350 $489,000

265

53M

316K

127K

Ticker LIVN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 53,545,700
Market Cap $2.58B
Description
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mackenzie Financial Corp with notifications on news.